Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Monoclonal antibodies specific to the plexin-semaphorin-integrin (PSI) domain of RON for drug delivery and its application in cancer therapy

Monoclonal antibodies specific to the plexin-semaphorin-integrin (PSI) domain of RON for drug delivery and its application in cancer therapy

US Patent 11208494 · Granted Dec 28, 2021

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Lighting fixture2025
Turtle aromatherapy wax melting lamp2024
Turtle plant pot2024
Lymphocyte activation gene-3 (LAG-3) binding antibody and use thereof2023
Solar turtle statue2023
Preparation and use of anti-MET-and-RON bispecific antibody and antibody-drug co2023
Preparation and use of anti-MET-and-RON bispecific antibody and antibody-drug co2023
Turtle plant pot2023
Turtle ashtray2023
Photocatalysis extraction method for enriching cannabidiol from the wild hemps2022
Nanocomplexes of modified peptides or proteins2021
Nanocomplexes for delivery of saporin2020